LONDON — GlaxoSmithKline and McLaren Group have entered a long-term strategic partnership.
Running initially until 2016, McLaren will help deliver world-class performance across GSK’s global businesses, including its Consumer Healthcare, manufacturing and research and development divisions.
Also part of the agreement, the companies will build a new state-of-the-art learning facility, McLaren GSK Centre for Applied Performance, which will focus on developing U.K. engineering skills and processes. It will be located at McLaren’s headquarters in Woking, England, and open in 2013.
“I am delighted to announce this partnership with McLaren, which brings together two British companies whose continued success hinges on the ability to innovate and rapidly respond to change and competitor activity. McLaren has an unparalleled reputation for innovation built on rigorous analytics and fast decision making,” GSK CEO Andrew Witty said. “This partnership is another example of GSK looking outside its sector for inspiration and fresh perspectives on how we can achieve our strategic goals in an ever more challenging and fast changing business environment.”